CommercialCoverageMedium impact
07.02.22j, Esophagogastroduodenoscopy (EGD) and Endoscopic Retrograde Cholangiopancreatography (ERCP)
Independence Blue Cross·Gastroenterology, General Surgery, Internal Medicine·Medical Policy
Effective date
Oct 1, 2025
We identified it
Jun 19, 2026
Summary
Independence Blue Cross reissued policy 07.02.22j on EGD and ERCP procedures, effective 10/01/2025, with granular ICD-10 code refinements. Specific abdominal and flank pain diagnosis codes (R10.21, R10.22, R10.23, R10.24, R10.85, R10.8A1-A3, R10.8A9, R10.A1-A3, R76.89) are now classified as NOT medically necessary for EGD, replacing broader codes (R10.2, R76.8). Billing teams must update claim denial logic and prior authorization systems to deny EGD claims when these specific diagnosis codes are the sole or primary justification.
Action Required
By 09/30/2025: Billing team must update claim submission and denial logic in billing software to identify and deny EGD claims (CPT 43233, 43235, 43236, 43237, HCPCS C7541, C7542) when ICD-10 codes R10.21, R10.22, R10.23, R10.24, R10.85, R10.8A1, R10.8A2, R10.8A3, R10.8A9, R10.A1, R10.A2, R10.A3, or R76.89 are the sole or primary diagnosis justification. Remove previously blocked codes R10.2 and R76.8 from denial rules. Update prior authorization workflows to flag these diagnosis codes as non-qualifying for medical necessity. Inform providers via bulletin that EGD procedures for isolated abdominal/flank pain or abnormal immunological findings will not be covered. Failure to implement will result in claim denials and potential overpayment recovery.